Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David, Cesarz"'
Autor:
David Bryant Batt, Run-Ming B. Wang, Peng Geng, Markus Bänziger, Tim Ramsey, Lawrence Blas Perez, Francis Taplin, Richard William Versace, David Cesarz, Wolfgang Marterer, Walter Michael, Naeem Yusuff, Donatienne Denni-Dischert
Publikováno v:
Organic Process Research & Development. 10:70-77
A scaleable synthetic route to [4,7‘]bis-isoquinolinyl-1-yl-(2-tert-butyl-pyrimidine-5-yl)amine (1), an inhibitor of B-Raf kinase is described. The key step in the synthesis is the Pd-catalyzed Negishi coupling of 4-bromo-1-chloroisoquinoline with
Autor:
Stacy W. Remiszewski, Lidia C. Sambucetti, Kenneth W. Bair, John Bontempo, David Cesarz, Nagarajan Chandramouli, Ru Chen, Min Cheung, Susan Cornell-Kennon, Karl Dean, George Diamantidis, Dennis France, Michael A. Green, Kobporn Lulu Howell, Rina Kashi, Paul Kwon, Peter Lassota, Mary S. Martin, Yin Mou, Lawrence B. Perez, Sushil Sharma, Troy Smith, Eric Sorensen, Francis Taplin, Nancy Trogani, Richard Versace, Heather Walker, Susan Weltchek-Engler, Alexander Wood, Arthur Wu, Peter Atadja
Publikováno v:
Journal of Medicinal Chemistry. 46:4609-4624
A series of N-hydroxy-3-phenyl-2-propenamides were prepared as novel inhibitors of human histone deacetylase (HDAC). These compounds were potent enzyme inhibitors, having IC50s < 400 nM in a partially purified enzyme assay. However, potency in cell g
Autor:
John Bontempo, Jagoe Christopher Turchik, Yin Mou, Ania M. Czuchta, Penny E. Phillips, Kenneth W. Bair, Frederick Ray Kinder, Long D. Tran, Sonya Zabludoff, Steven Chen, Run-Ming Wang, David Cesarz, Raphael Nemzek, Richard William Versace, Susan Weltchek, Phillip Crews
Publikováno v:
Journal of Medicinal Chemistry. 44:3692-3699
Bengamide B, a novel sponge-derived marine natural product with broad spectrum antitumor activity, was not suitable for further preclinical development because of its difficult synthesis and very poor water solubility. Bengamide B produced a 31% T/C
Autor:
Stacy W, Remiszewski, Lidia C, Sambucetti, Kenneth W, Bair, John, Bontempo, David, Cesarz, Nagarajan, Chandramouli, Ru, Chen, Min, Cheung, Susan, Cornell-Kennon, Karl, Dean, George, Diamantidis, Dennis, France, Michael A, Green, Kobporn Lulu, Howell, Rina, Kashi, Paul, Kwon, Peter, Lassota, Mary S, Martin, Yin, Mou, Lawrence B, Perez, Sushil, Sharma, Troy, Smith, Eric, Sorensen, Francis, Taplin, Nancy, Trogani, Richard, Versace, Heather, Walker, Susan, Weltchek-Engler, Alexander, Wood, Arthur, Wu, Peter, Atadja
Publikováno v:
Journal of medicinal chemistry. 46(21)
A series of N-hydroxy-3-phenyl-2-propenamides were prepared as novel inhibitors of human histone deacetylase (HDAC). These compounds were potent enzyme inhibitors, having IC(50)s400 nM in a partially purified enzyme assay. However, potency in cell gr
Autor:
Paul Kirschmeier, Thomas F. Hendrickson, Remiszewski Stacy W, Wess A. Sisson, Doll Ronald J, Birendra N. Pramanik, Ashit K. Ganguly, David Cesarz, and Anthony Tsarbopoulos, Steve E. Webber, Eric C. Huang, Yu-Sen Wang, Joan E. Brown, Viyyoor M. Girijavallabhan, Robert A. Love, Bancha Vibulbhan, Taveras Arthur G, Robert M. Aust, Mark E. Snow, J. del Rosario, Edward L. Brown, Shella A. Fuhrman, Larry Heimark, and J. Ernest Villafranca, Charles R. Kissinger, D. M. Delisle
Publikováno v:
Biochemistry. 37(45)
Mutated, tumorigenic Ras is present in a variety of human tumors. Compounds that inhibit tumorigenic Ras function may be useful in the treatment of Ras-related tumors. The interaction of a novel GDP exchange inhibitor (SCH-54292) with the Ras-GDP pro